<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
  <channel>
    <title>HATIP blog</title>
    <description> </description>
    <link>http://www.aidsmap.com///page/1506853/</link>
    <docs>http://backend.userland.com/rss</docs>
    <generator>RSS.NET: http://www.rssdotnet.com/</generator>
    <item>
      <title>Why is the world's largest IPT programme not even bigger?</title>
      <description>As
Professor van der Walt said in an
interview with me at the South African TB conference, there is a
push to get South Africa to provide continuous isoniazid preventive therapy
(IPT) to people with HIV without symptoms of TB. </description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2441242/</guid>
    </item>
    <item>
      <title>AIDS 2012: TB/HIV road map, and TB/HIV advocacy networking zone</title>
      <description>
</description>
      <author>Anon</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2438662/</guid>
    </item>
    <item>
      <title>Aurum Institute launches `Managing TB in a New Era of Diagnostics`</title>
      <description>A new tool to assist primary health care nurses managing TB &amp;amp;
TB-HIV </description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2436905/</guid>
    </item>
    <item>
      <title>South African TB conference: an interview with conference co-chair Martie van der Walt</title>
      <description>"This conference is on tuberculosis TB/HIV integration but
when you can actually look at what is going on in the health services over all,
there's very little integration really," said Professor Martie van der Walt, who
currently heads the TB research unit of South Africa's Medical Research
Council. </description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2433907/</guid>
    </item>
    <item>
      <title>GeneXpert MTB/RIF: new developments on uptake and pricing</title>
      <description>The advocacy pre-meeting at the South African TB Conference started with a presentation on GeneXpert
and the need for affordable TB diagnostics by Colleen Daniels, formerly with WHO's STOP TB Department, but now the Senior Policy
Associate for TB with the Treatment Action Group (TAG), a rather remarkable
coup for the organisation. She provided some interesting data on the early uptake of the Xpert MTB/Rif test for TB, which was covered in a recent series of HATIP editions.</description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2398133/</guid>
    </item>
    <item>
      <title>The TB activist agenda in southern Africa: more from the South African TB conference</title>
      <description>Participants
at the Treatment Action Campaign, SECTION27, Médecins Sans Frontières and Oxfam pre-meeting we mentioned last week identified five crucial
interventions to reduce TB cases and mortality in South Africa.</description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2397011/</guid>
    </item>
    <item>
      <title>Register for `Transforming the HIV/TB response: Defining the next 10 years`</title>
      <description>WHO's STOP TB programme is organising a consultation
immediately prior to AIDS 2012 in Washington
 DC, in order to generate
innovative ideas on the next ten years of the HIV/TB response. The consultation will be co-hosted by Diane Havlir of University of San Francisco
and the Chair of the Global TB/HIV Working Group and co-Chair of AIDS 2012 and
Mark Dybul of the Georgetown University
and George W Bush Institute and formerly the US Global AIDS Coordinator, and
convened by Haileyesus Getahun of the Stop TB Department of WHO.</description>
      <author>Anon</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2396893/</guid>
    </item>
    <item>
      <title>Six months of South African TB activism </title>
      <description>Whenever a major HIV and TB conference takes
place in South Africa, one has come to expect a significant activist presence -
and at least under the current minister of health - engagement. With groups
like the Treatment Action Campaign (TAC) - arguably the most renowned treatment
activist organization since ACT UP New York - and its natural allies, Médecins
sans Frontières (MSF) and Section 27 (the legal wonks formerly known as the
AIDS Law Project), activism and campaigns are sometimes as much on show as the
clinical science - and often far more impactful.</description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2393547/</guid>
    </item>
    <item>
      <title>Working together to call for better TB lab technologies</title>
      <description>A key issue expected to be highlighted at
the 3rd South African TB Conference this week in Durban is demand for new TB diagnostics and
new approaches to managing TB.</description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2389911/</guid>
    </item>
    <item>
      <title>Third South Africa TB Conference and pre-meeting hosted by Treatment Action Campaign (TAC), Médecins Sans Frontières (MSF), SECTION27 next Tuesday, 12 June</title>
      <description>
</description>
      <author>Anon</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2384914/</guid>
    </item>
    <item>
      <title>Upcoming events at AIDS 2012 and 43rd World Lung Health conference </title>
      <description>We'd like to draw attention to events at several upcoming
conferences, and to remind you that registration for the 43rd Union
World Conference on Lung Health is now open.</description>
      <author>Keith Alcorn</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2382048/</guid>
    </item>
    <item>
      <title>Implementing collaborative TB-HIV activities: a programmatic guide</title>
      <description>A new
practical guide for healthcare workers and HIV and tuberculosis (TB) programmes
on how to implement TB-HIV collaborative activities (health services that
reduce the burden of either TB or HIV, and sometimes both diseases, as well as
the activities required to support those services) has just been released by
the the Union (the International Union Against Tuberculosis and Lung Disease).</description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2368779/</guid>
    </item>
    <item>
      <title>Do new diagnostic tests render a study of empiric TB treatment unethical?</title>
      <description>One of the
'discussions in the corridors' at the Union World Conference on Lung Health in
Lille in October last year, was about the ethics of a study known as 'ACTG 5274' or the 'REMEMBER' trial. REMEMBER stands for
'Reducing Early
Mortality and Early Morbidity by Empiric Tuberculosis (TB) Treatment Regimens'.
Giving someone 'empiric' treatment means treating them for something they might
have, before it has been confirmed. The
study was described in this blog a couple of months ago - it is
recruiting people with HIV who present late for care (e.g. are diagnosed with a
CD4 cell count below 50). In the study, people are randomly assigned to one of
two groups:</description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2367222/</guid>
    </item>
    <item>
      <title>UNITAID seeks proposals on ways to increase access to TB, HIV and malaria medicines</title>
      <description>Funding opportunity
for proposals to increase access to TB, HIV and malaria medicines, treatment and diagnostics in low
and middle-income countries - deadline 22
May 2012</description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2356474/</guid>
    </item>
    <item>
      <title>What needs to be done in other countries and globally to respond to drug-resistant TB?</title>
      <description>Any setting where there is a significant burden of drug
resistant TB would do well to adopt the key steps being taken in Mumbai. </description>
      <author>Anon</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2271833/</guid>
    </item>
    <item>
      <title>What is being done about TDR-TB in Mumbai?</title>
      <description>"It is still possible for public health
systems to take a pro-active step, as the Mumbai officials are now doing to
stem the problem," Dr Dewan told India Together. "TB Control in Mumbai can be
transformed. The challenge is to ensure that all TB patients get the support
they need and that would prevent the emergence of drug resistance
strains."</description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2271801/</guid>
    </item>
    <item>
      <title>WHO recommendations on actions to address the impact of TB on maternal neonatal and child health</title>
      <description>To coincide with World TB Day, members of WHO's STOP TB Department published
a piece in a special Tuberculosis and TB/HIV Supplement of the Journal of
Infectious Diseases that lays out the case for improving access to TB
prevention, diagnosis and treatment services for pregnant women and their
children. They call for the following "low-cost, effective interventions" to be
made a routine part of the integrated management of pregnancy and child health
in much the same way as TB collaborative activities are now part of standard of
care for HIV programmes in resource-constrained settings.</description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2328055/</guid>
    </item>
    <item>
      <title>Did Udwadia et al do the right thing with their reports of TDR-TB?</title>
      <description>In the last post, we reviewed the
backstory regarding a report in Clinical
Infectious Diseases by Udwadia et al on the detection of TB cases at a
hospital in Mumbai, India, that lab tests suggested were resistant to all of
the anti-TB medications the hospital could get hold of, and which were thus
classified as being totally drug resistant-TB (TDR-TB). </description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2270555/</guid>
    </item>
    <item>
      <title>'TDR-TB' is nothing new, unless it stands for `Triggering Dramatic Responses`  to tuberculosis becoming harder to treat</title>
      <description>In what is by now old news, a little more than a month
ago, a report in the journal Clinical Infectious
Diseases from a hospital in Mumbai, India, described several cases
of tuberculosis that drug sensitivity testing (DST) in the facility's lab
suggested were resistant to pretty much any anti-TB medication they could throw
at it (12 first and second line TB drugs in all).1
</description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2255720/</guid>
    </item>
    <item>
      <title>More evidence to show that cotrimoxazole is still an essential medicine for people with HIV</title>
      <description>Two must-read studies published this month reinforce the
case for cotrimoxazole prophylaxis in people living with HIV in low and
middle-income settings.</description>
      <author>Keith Alcorn</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2252396/</guid>
    </item>
    <item>
      <title>New TB/HIV research you want to share? Make a note of these abstract deadlines.</title>
      <description>The deadline for abstract submissions to the
19th International AIDS Conference (AIDS 2012) is fast approaching.
The deadline is February 15th 2012. 
</description>
      <author>Keith Alcorn</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2232605/</guid>
    </item>
    <item>
      <title>Diagnostics and active case finding for TB: what are more sensitive tests actually detecting?</title>
      <description>The current HATIP article is the first in a two-part
series on developing lab capacity - to support more active TB case finding.
Active case finding is important to more quickly identify and diagnose cases of
TB that might not otherwise have been diagnosed, and reduce the opportunity for
these cases to spread TB in the communities.</description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2221186/</guid>
    </item>
    <item>
      <title>The basis for the REMEMBER trial </title>
      <description>REMEMBER
stands for 'Reducing
Early Mortality and Early Morbidity by Empiric Tuberculosis (TB) Treatment
Regimens' and is a randomised controlled trial that is currently enrolling at
the international ACTG sites in a number of resource-limited countries. </description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2214676/</guid>
    </item>
    <item>
      <title>ART for TB prevention (&amp; HIV) Studies, Planned or Underway</title>
      <description>One of the recent editions of HATIP published in November 2011 addressed
the extent to antiretroviral therapy (ART) could be used to reduce the burden
of TB. There is no doubt that after the first few months of treatment ART
dramatically decreases the risk of active TB in people living with advanced HIV
disease - the question is how much of an effect it has on the risk of TB in
HIV-positive people with higher CD4 cell counts. </description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2212436/</guid>
    </item>
    <item>
      <title>A nurse demystifies the initiation of treatment in infants with HIV at the Paediatric AIDS Treatment for Africa Forum</title>
      <description>"A nurse can initiate
antiretroviral therapy (ART) and treat children with HIV, a common, manageable paediatric condition," said Sister
Martha Mashele, who shared how she overcame her fears and empowered herself to
initiate ART and thus, save the lives of children with HIV, before a crowd of
doctors, nurses, pharmacists and counsellors gathered at the Paediatric AIDS
Treatment for Africa Forum held in Gaborone, Botswana in November 2011. </description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2204257/</guid>
    </item>
    <item>
      <title>Team PATA: improving HIV care for children through action learning</title>
      <description>"Our conferences are very different to any other, our PATA
Forums," said Dr Paul Cromhout of the Small Projects Foundation (which works in
community development in the Eastern Cape of South Africa), but who also serves
on the steering committee of Paediatric AIDS Treatment in Africa (PATA),
sometimes called Team PATA. 
</description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2157066/</guid>
    </item>
    <item>
      <title>Cameroon: Les Droit Humans Comptent!</title>
      <description>It
can be a very powerful tool for advocacy when people living with HIV can
document human rights violations that they experience in their own communities 
- particularly when they don't shy away from what some may see as sensitive topics, like the experiences of
HIV-positive men who have sex with men, according to Calorine Kenkem of Le Réseau Camerounais des Associations de Personnes Vivants avec le VIH
(the Cameroonian Network of Associations of People Living with HIV) or
RéCAP+. She
was speaking at the 3rd HIV Leadership through Accountability (LTA)
Planning and Review Meeting, held this July in Nairobi, Kenya.
</description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2133637/</guid>
    </item>
    <item>
      <title>Winstone Zulu's contribution to HIV and TB activism</title>
      <description>As
noted elsewhere on aidsmap, Winstone Zulu, the first
Zambian to come out publicly about his HIV-positive status (in 1990) who later
went on to become one of the very first TB-HIV activists, has passed away. &amp;#160;We thought there was some more to add about
the contribution that he made to activism, in both his own and his colleagues
words. </description>
      <author>Anon</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2107700/</guid>
    </item>
    <item>
      <title>Sexual and reproductive health rights in adolescents living with HIV</title>
      <description>Sexual and reproductive health rights for
people living with HIV have begun to receive greater recognition in the past
few years, as a result of advocacy by people living with HIV.</description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/2087258/</guid>
    </item>
    <item>
      <title>Afya Bora, Utu na Kinga (Positive Health Dignity and Prevention in Swahili)</title>
      <description>"Positive Health Dignity and Prevention (PHDP) is an
empowering concept that has managed to bring together the diverse networks of people living with HIV
(PLHIV) in Tanzania to
work towards one important goal that we are passionate about," said Sammy
Musunga, of the National Council for People Living with HIV and AIDS
(NACOPHA). Speaking at a board meeting of the Global Network of People Living
with HIV/AIDS (GNP+), held in Cape Town early in April, Musunga described some of the
challenges and successes introducing Positive Health Dignity and Prevention
(PHDP), a new HIV prevention framework developed by people living with HIV,
into his country. </description>
      <author>Anon</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/1793648/</guid>
    </item>
    <item>
      <title>Strengthening advocacy by documenting the experience of people living with HIV</title>
      <description>NEPHAK's
experience with the HIV Leadership through Accountability Programme</description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/1772528/</guid>
    </item>
    <item>
      <title>Is South Africa's revamped response to the TB epidemic the start of a healthcare delivery revolution?</title>
      <description>"If anybody here, or anywhere else today, believes we are
over-exaggerating the problems of HIV/AIDS and TB, they are living in a fool's paradise," said Dr
Aaron Motsoaledi, South
  Africa's progressive Minister of Health last
week at an event commemorating World TB Day. "HIV/AIDS and TB together
constitute the worst public health care crisis this country has ever been faced with." </description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/1746797/</guid>
    </item>
    <item>
      <title>GeneXpert to be rolled out as first-line diagnostic for TB in South Africa</title>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/1746803/</guid>
    </item>
    <item>
      <title>Model facilities for MDR-TB care</title>
      <description>For a number of journalists (myself included), World
TB Day marked the third consecutive day of a media tour providing mostly local
press with the background on the TB and drug-resistant TB epidemic to highlight
DOH's efforts where it is most needed - particularly in the province of KwaZulu
Natal (KZN). </description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/1746807/</guid>
    </item>
    <item>
      <title>South Africa's TB contact tracing plans: is taking health to the people the new priority?</title>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/1746854/</guid>
    </item>
    <item>
      <title>Preventing TB in people with HIV - a reminder on some new resources</title>
      <description>Full details of the study which contributed to the
development of new WHO guidance on intensified case finding for tuberculosis in
people with HIV infection have now been published in PLoS
Medicine, and the full text is freely available.</description>
      <author>Anon</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/1615495/</guid>
    </item>
    <item>
      <title>Subsidising private insurance to strengthen health services in Africa</title>
      <description>"If you look at the figures, the big problem is there just isn't enough
money for healthcare in Sub-Saharan Africa. And if you look at population
versus burden of disease and then look at total health expenditure, there is something fundamentally
wrong," said Dr Joep Lange, Founder and Chairman of the PharmAccess Foundation.
</description>
      <author>Anon</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/1530833/</guid>
    </item>
    <item>
      <title>New drug sensitivity testing in the field - a reality check from Khayelitsha</title>
      <description>The staged introduction of new TB
drug sensitivity testing technologies to improve MDR-TB case detection in
Khayelitsha</description>
      <author>Anon</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/1523900/</guid>
    </item>
    <item>
      <title>Family-centred care and children with HIV -  what's the reality on the ground?</title>
      <description>I am in the process of pulling together an article about family-centred care as a means to improve the treatment outcomes of HIV-infected children. </description>
      <author>Carole Leach-Lemens</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/1513234/</guid>
    </item>
    <item>
      <title>Dr Illia Podolyan - in detention in Ukraine for legally providing opioid substitution therapy for people who inject drugs </title>
      <description>"I have been
working with opioid substitution therapy (OST) programmes for the last 4 years
and I can tell you,
honestly, that sometimes I am tired of it. Sometimes I feel so fed up with all
of these clients and I feel like quitting because it really is difficult," Dr Illia
Podolyan, chief narcologist of the Odessa Regional Narcological Dispensary,
told me last October when I was on a trip in Ukraine to see how that
country was, haltingly, rolling out integrated TB/HIV and OST care for people
who inject drugs (PWID).</description>
      <author>Anon</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/1512679/</guid>
    </item>
    <item>
      <title>TB patient incarcerated in the US and some more posts from our panel regarding the CAMELIA Study</title>
      <description>This post is just a brief update to report on another
case where a TB patient was incarcerated and to relate an important comment in
response to a query from a previous HATIP article. 
</description>
      <author>Anon</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/1511426/</guid>
    </item>
    <item>
      <title>Imprisoning TB patients: is this really a smart way to manage non-adherence?</title>
      <description>About
two weeks ago, the
Associated Press ran a story reporting that two men had been sentenced to
Kapsabet prison in western Kenya for
8 months. Their crime? Not adhering to their TB regimen. </description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/1506861/</guid>
    </item>
    <item>
      <title>Introducing the HATIP blog</title>
      <description>This is the first post to the new HATIP blog, a forum where
we hope to discuss some of the implications of new research, guidelines and
news on the practice of delivering care for HIV, TB and other health services
in resource-constrained settings - as well as discuss some of the topics we are
currently working on. </description>
      <author>Theo Smart</author>
      <guid isPermaLink="True">http://www.aidsmap.com///page/1509310/</guid>
    </item>
  </channel>
</rss